Breast Cancer Clinical Trial
Tempus Priority Study: A Pan-tumor Observational Study
Summary
Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.
Full Description
The Study will collect combined clinical and molecular health information for cancer patients in the United States from multiple academic medical centers and community oncology practices. Participants who agree to join the Study will have their molecular profiling results, associated clinical health information, and longitudinal outcomes health information collected by the participating Institution for submission to Tempus. The specific goal of the Study is to create an outcomes-based dataset for future research to improve cancer treatment.
Eligibility Criteria
Inclusion Criteria:
Solid or hematologic malignancy.
Willing and able to provide informed consent where required.
Has received or will receive genomic profiling.
Exclusion Criteria:
Individuals without the capacity to consent.
Prisoners at the time of enrollment.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 12 Locations for this study
Napa California, 94558, United States
Indianapolis Indiana, 46250, United States
Covington Louisiana, 70433, United States
Bolivar Missouri, 65613, United States
Belleville New Jersey, 07109, United States
New York New York, 10016, United States
Cincinnati Ohio, 45220, United States
Columbus Ohio, 43214, United States
Tulsa Oklahoma, 74146, United States
York Pennsylvania, 17403, United States
How clear is this clinincal trial information?